Sitagliptin Phosphate Tablets IP 50 mg

Composition
Each film coated tablet contains
Sitagliptin Phosphate Monohydrate IP
equivalent to Sitagliptin — 50 mg
Excipients — q.s.
Color - Titanium Dioxide IP

Therapeutic Category
Anti-diabetic Drugs

Sitagliptin Phosphate Tablets IP 100 mg

Composition
Each film coated tablet contains
Sitagliptin Phosphate Monohydrate IP
equivalent to Sitagliptin — 100 mg
Excipients — q.s.
Color - Titanium Dioxide IP

Therapeutic Category
Anti-diabetic Drugs

Sitagliptin Phosphate 50 mg and Metformin Hydrochloride 500 mg Tablets

Composition
Each film coated tablet contains
Sitagliptin Phosphate Monohydrate IP
equivalent to Sitagliptin — 50 mg
Metformin Hydrochloride IP — 500 mg
Excipients — q.s.
Color - Titanium Dioxide IP

Therapeutic Category
Anti-diabetic Drugs

Sitagliptin Phosphate 50 mg and Metformin Hydrochloride 1000 mg Tablets

Composition
Each film coated tablet contains
Sitagliptin Phosphate Monohydrate IP
equivalent to Sitagliptin — 50 mg
Metformin Hydrochloride IP — 1000 mg
Excipients — q.s.
Color - Titanium Dioxide IP

Therapeutic Category
Anti-diabetic Drugs

Teneligliptin Tablets 20 mg

Composition
Each film coated tablet contains
Teneligliptin Hydrobromide Hydrate
equivalent to Teneligliptin — 20 mg
Excipients — q.s.
Color - Titanium Dioxide IP

Therapeutic Category
Anti-diabetic Drugs

Teneligliptin 20 mg and Metformin Hydrochloride 500 mg Tablets

Composition
Each uncoated tablet contains
Teneligliptin Hydrobromide Hydrate
equivalent to Teneligliptin — 20 mg
Metformin Hydrochloride IP — 500 mg
Excipients — q.s.

Therapeutic Category
Anti-diabetic Drugs

Vildagliptin Tablets IP 50 mg

Composition
Each film coated tablet contains
Vildagliptin IP — 50 mg
Excipients — q.s.
Color - Titanium Dioxide IP

Therapeutic Category
Anti-diabetic Drugs

Vildagliptin 50 mg and Metformin Hydrochloride 500 mg Tablets

Composition
Each film coated tablet contains
Vildagliptin IP — 50 mg
Metformin Hydrochloride IP — 500 mg
Excipients — q.s.
Color - Titanium Dioxide IP

Therapeutic Category
Anti-diabetic Drugs

Vildagliptin 50 mg and Metformin Hydrochloride 1000 mg Tablets

Composition
Each film coated tablet contains
Vildagliptin IP — 50 mg
Metformin Hydrochloride IP — 1000 mg
Excipients — q.s.
Color - Titanium Dioxide IP

Therapeutic Category
Anti-diabetic Drugs

Linagliptin Tablets 5 mg

Composition
Each film coated tablet contains
Linagliptin — 5 mg
Excipients — q.s.
Color - Titanium Dioxide IP

Therapeutic Category
Anti-diabetic Drugs

Glimepiride Tablets IP 1 mg

Composition
Each uncoated tablet contains
Glimepiride IP — 1 mg
Excipients — q.s.

Therapeutic Category
Anti-diabetic Drugs

Glimepiride Tablets IP 2 mg

Composition
Each uncoated tablet contains
Glimepiride IP — 2 mg
Excipients — q.s.

Therapeutic Category
Anti-diabetic Drugs

Glimepiride 1 mg and Metformin Hydrochloride 500 mg Tablets

Composition
Each uncoated tablet contains
Glimepiride IP — 1 mg
Metformin Hydrochloride IP — 500 mg
Excipients — q.s.

Therapeutic Category
Anti-diabetic Drugs

Glimepiride 2 mg and Metformin Hydrochloride 500 mg Tablets

Composition
Each uncoated tablet contains
Glimepiride IP — 2 mg
Metformin Hydrochloride IP — 500 mg
Excipients — q.s.

Therapeutic Category
Anti-diabetic Drugs

Glimepiride 1 mg and Metformin Hydrochloride 500 mg Sustained Release Tablets

Composition
Each uncoated tablet contains
Glimepiride IP — 1 mg
Metformin Hydrochloride IP — 500 mg
(as sustained release form)
Excipients — q.s.

Therapeutic Category
Anti-diabetic Drugs

Glimepiride 2 mg and Metformin Hydrochloride 500 mg Sustained Release Tablets

Composition
Each uncoated tablet contains
Glimepiride IP — 2 mg
Metformin Hydrochloride IP — 500 mg
(as sustained release form)
Excipients — q.s.

Therapeutic Category
Anti-diabetic Drugs

Gliclazide Modified Release Tablets 60 mg

Composition
Each uncoated modified release tablet contains
Gliclazide IP — 60 mg
Excipients — q.s.

Therapeutic Category
Anti-diabetic Drugs

Gliclazide Tablets IP 80 mg

Composition
Each uncoated tablet contains
Gliclazide IP — 80 mg
Excipients — q.s.

Therapeutic Category
Anti-diabetic Drugs

Gliclazide 80 mg and Metformin Hydrochloride 500 mg Tablets

Composition
Each uncoated tablet contains
Gliclazide IP — 80 mg
Metformin Hydrochloride IP — 500 mg
Excipients — q.s.

Therapeutic Category
Anti-diabetic Drugs

Dapagliflozin Tablets 10 mg

Composition
Each film coated tablet contains
Dapagliflozin Propanediol Monohydrate
equivalent to Dapagliflozin — 10 mg
Excipients — q.s.
Color - Titanium Dioxide IP

Therapeutic Category
Anti-diabetic Drugs

Dapagliflozin 10 mg and Metformin Hydrochloride 500 mg Tablets

Composition
Each film coated tablet contains
Dapagliflozin — 10 mg
Metformin Hydrochloride IP — 500 mg
Excipients — q.s.

Therapeutic Category
Anti-diabetic Drugs

Metformin Hydrochloride Tablets IP 500 mg

Composition
Each uncoated tablet contains
Metformin Hydrochloride IP — 500 mg
Excipients — q.s.

Therapeutic Category
Anti-diabetic Drugs

Repaglinide Tablets IP 0.5 mg

Composition
Each uncoated tablet contains
Repaglinide IP — 0.5 mg
Excipients — q.s.

Therapeutic Category
Anti-diabetic Drugs

Repaglinide Tablets IP 1 mg

Composition
Each uncoated tablet contains
Repaglinide IP — 1 mg
Excipients — q.s.

Therapeutic Category
Anti-diabetic Drugs

Voglibose Tablets IP 0.2 mg

Composition
Each uncoated tablet contains
Voglibose IP — 0.2 mg
Excipients — q.s.

Therapeutic Category
Anti-diabetic Drugs

Voglibose Tablets IP 0.3 mg

Composition
Each uncoated tablet contains
Voglibose IP — 0.3 mg
Excipients — q.s.

Therapeutic Category
Anti-diabetic Drugs